518 related articles for article (PubMed ID: 17916152)
1. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
Alcalai R; Seidman JG; Seidman CE
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152
[TBL] [Abstract][Full Text] [Related]
2. Genetic basis of hypertrophic cardiomyopathy.
Lind JM; Chiu C; Semsarian C
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
[TBL] [Abstract][Full Text] [Related]
3. Novel locus for an inherited cardiomyopathy maps to chromosome 7.
Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY
Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy: from gene defect to clinical disease.
Chung MW; Tsoutsman T; Semsarian C
Cell Res; 2003 Feb; 13(1):9-20. PubMed ID: 12643345
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
6. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
Keren A; Syrris P; McKenna WJ
Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
[TBL] [Abstract][Full Text] [Related]
10. The pathology of hypertrophic cardiomyopathy.
Hughes SE
Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder.
Doolan A; Nguyen L; Semsarian C
Heart Lung Circ; 2004 Mar; 13(1):15-25. PubMed ID: 16352163
[TBL] [Abstract][Full Text] [Related]
12. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.
Orenes-Piñero E; Hernández-Romero D; Jover E; Valdés M; Lip GY; Marín F
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):521-30. PubMed ID: 21507890
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic cardiomyopathy: an update.
McKenna WJ
Cardiologia; 1993 Dec; 38(12 Suppl 1):277-81. PubMed ID: 8020027
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
Bos JM; Towbin JA; Ackerman MJ
J Am Coll Cardiol; 2009 Jul; 54(3):201-11. PubMed ID: 19589432
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy: current understanding and treatment objectives.
Soor GS; Luk A; Ahn E; Abraham JR; Woo A; Ralph-Edwards A; Butany J
J Clin Pathol; 2009 Mar; 62(3):226-35. PubMed ID: 18930982
[TBL] [Abstract][Full Text] [Related]
18. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
[TBL] [Abstract][Full Text] [Related]
19. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
Brito D; Madeira H
Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
[TBL] [Abstract][Full Text] [Related]
20. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
